Annie Talbot

Back to Profile

Publication Details

  • Switch from Enfuvirtide to Raltegravir in patients with indetectable viral load: Efficacy and safety at 24 weeks in a Montreal Cohort

    Annie Talbot, N Machouf, R Thomas, S Marcotte, R Therrien, B Lessard, S Dufresne, R Lalonde. JAIDS. 2009; 51 (3): 361-364

Stanford Medicine Resources:

Footer Links: